Tratamiento neurohormonal de la insuficiencia cardíaca / Heart failure. Neurohormonal treatment
Arch. cardiol. Méx
; 77(supl.4): S4-106-S4-110, oct.-dic. 2007.
Article
in Spanish
| LILACS
| ID: lil-568712
Responsible library:
BR1.1
ABSTRACT
Two hypothesis on the cause of heart failure (HF) have been postulated, one of hemodynamic character and another one of neurohormonal nature. According to the second one, HF is consequence of the overactivity of endogenous endocrine systems such as the renin-angiotensin aldosterone or the autonomic system. Angiotensin-II blockage is actually the first option in the medical treatment of HF. Since it reduces cardiac and vascular remodelation, synthesis of collagen and improves the endothelial function. Preceding to this option one can find the use of beta adrenergic blochers. Recently it was discovered that atrial myocardium liberates, in response to stretching, several peptides with natriuretic properties, specially one denominated B. Such compound has utility in the treatment of decompensated heart failure exclusively in hospitalized patients.
Full text:
Available
Collection:
International databases
Database:
LILACS
Main subject:
Heart Failure
Limits:
Humans
Language:
Spanish
Journal:
Arch. cardiol. Méx
Journal subject:
Cardiology
Year:
2007
Document type:
Article
Affiliation country:
Mexico
Institution/Affiliation country:
Instituto Nacional de Cardiología Ignacio Chávez/MX